Gedatolisib in combination with palbociclib and endocrine therapy in women with hormone receptor-positive, HER2-negative advanced breast cancer: results from the dose expansion groups of an open-label, phase 1b study
Titel:
Gedatolisib in combination with palbociclib and endocrine therapy in women with hormone receptor-positive, HER2-negative advanced breast cancer: results from the dose expansion groups of an open-label, phase 1b study
Auteur:
Layman, Rachel M Han, Hyo S Rugo, Hope S Stringer-Reasor, Erica M Specht, Jennifer M Dees, E Claire Kabos, Peter Suzuki, Samuel Mutka, Sarah C Sullivan, Brian F Gorbatchevsky, Igor Wesolowski, Robert